Neurala Biosciences is an Australian clinical-stage biotechnology company developing second-generation psychedelic neuromedicines for depression, PTSD, and other serious mental health conditions
Neurala Biosciences is an Australian clinical-stage biotechnology company developing second-generation psychedelic neuromedicines for depression, PTSD, and other serious mental health conditions. The company combines precision formulation design with advanced pharmaceutical science to deliver differentiated, IP-protected therapies.